Log on / register
Feedback | Support | My details
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis.
Williams-Herman D, Round E, Swern AS, Musser B, Davies MJ, Stein PP, Kaufman KD, Amatruda JM
BMC Endocr Disord 2008, 8:14
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses
Vora KA, Porter G, Peng R, Cui Y, Pryor K, Eiermann G, Zaller DM
BMC Immunology 2009, 10:19 (9 April 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.